Pharmedic Pharmaceutical Medicinal JSC (PMC) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

VND Million (Small Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.30

Return on Equity

35.58%

Price to Book

0.00

Revenue and Profits:

Net Sales:

132,255 Million

(Quarterly Results - Jun 2025)

Net Profit:

22,363 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

71.18%

6 Months

63.89%

1 Year

45.08%

2 Years

121.25%

3 Years

164.97%

4 Years

169.82%

5 Years

210.53%

Pharmedic Pharmaceutical Medicinal JSC for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

2.64%

EBIT Growth (5y)

2.48%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.56

Sales to Capital Employed (avg)

1.53

Tax Ratio

20.12%

Dividend Payout Ratio

273.90%

Pledged Shares

Institutional Holding

ROCE (avg)

79.55%

ROE (avg)

21.70%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

-0.77

EV to EBITDA

-0.70

EV to Capital Employed

-0.42

EV to Sales

-0.15

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

33.44%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.24% vs -8.31% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -1.48% vs 14.83% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "132,254.70",
          "val2": "125,668.50",
          "chgp": "5.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29,151.50",
          "val2": "29,184.20",
          "chgp": "-0.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "42.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "22,362.90",
          "val2": "22,699.40",
          "chgp": "-1.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "199.60%",
          "val2": "210.90%",
          "chgp": "-1.13%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.68% vs 2.73% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -4.11% vs 0.18% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "498,185.00",
          "val2": "485,186.40",
          "chgp": "2.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "101,916.30",
          "val2": "96,345.30",
          "chgp": "5.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "58,497.20",
          "val2": "61,002.00",
          "chgp": "-4.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "181.60%",
          "val2": "174.00%",
          "chgp": "0.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

132,254.70

125,668.50

5.24%

Operating Profit (PBDIT) excl Other Income

29,151.50

29,184.20

-0.11%

Interest

42.70

0.00

Exceptional Items

0.00

Consolidate Net Profit

22,362.90

22,699.40

-1.48%

Operating Profit Margin (Excl OI)

199.60%

210.90%

-1.13%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.24% vs -8.31% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -1.48% vs 14.83% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

498,185.00

485,186.40

2.68%

Operating Profit (PBDIT) excl Other Income

101,916.30

96,345.30

5.78%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

58,497.20

61,002.00

-4.11%

Operating Profit Margin (Excl OI)

181.60%

174.00%

0.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 2.68% vs 2.73% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -4.11% vs 0.18% in Dec 2023

All Annual Results

Company CV

About Pharmedic Pharmaceutical Medicinal JSC

Pharmedic Pharmaceutical Medicinal JSC

Pharmaceuticals & Biotechnology

Pharmedic Pharmaceutical Medicinal Joint Stock Company is a Vietnam-based company principally engaged in the manufacturing and distributing of pharmaceutical products, medicines, cosmetic and other products used in the healthcare sector. In addition, the Company is involved in the provision of printing services of plastic, paper and aluminum packagings. Moreover, it is active in the manufacture and trading of chemical products, such as pesticides and detergents for household and medical usage. During the year ended December 31, 2012, 97.24% of the Company's total revenue came from the sale of finished products. As of December 31, 2012, the Company was an affiliate of Saigon Pharmaceutical Company Limited (SAPHARCO), and it had a factory in Ho Chi Minh City, Vietnam.

Company Coordinates

Company Details

367 Nguyen Trai, Phuong Nguyen Cu Trinh, Quan 1 HO CHI MINH None : None

Tel: 84 8 38375300

http://www.pharmedic.com.vn

Registrar Details